DCLRE1B and pancreatic adenocarcinoma: The link between DCLRE1B expression and outcome was then investigated. As described previously, in many other cancer types such as ACC, KICH, KIRP, LAML, LGG, LIHC, MESO, PAAD, and SARC, high DCLRE1B expression was linked to a poor prognosis, demonstrating the potential of DCLRE1B as a pan-cancer biomarker for prognosis.